Cochrane Abstracts
Disease‐modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Disease‐modifying Antirheumatic Drugs (DMARDs) for Rheumatoid Arthritis After Failure of Biologic or Targeted Synthetic Therapy: a Systematic Review and Network Meta‐analysis." Cochrane Abstracts Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438879/all/Disease‐modifying_antirheumatic_drugs__DMARDs__for_rheumatoid_arthritis_after_failure_of_biologic_or_targeted_synthetic_therapy:_a_systematic_review_and_network_meta‐analysis.
Disease‐modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta‐analysis. Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/all/Disease‐modifying_antirheumatic_drugs__DMARDs__for_rheumatoid_arthritis_after_failure_of_biologic_or_targeted_synthetic_therapy:_a_systematic_review_and_network_meta‐analysis. Accessed October 5, 2026.
Disease‐modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta‐analysis. (2026). In Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/all/Disease‐modifying_antirheumatic_drugs__DMARDs__for_rheumatoid_arthritis_after_failure_of_biologic_or_targeted_synthetic_therapy:_a_systematic_review_and_network_meta‐analysis
Disease‐modifying Antirheumatic Drugs (DMARDs) for Rheumatoid Arthritis After Failure of Biologic or Targeted Synthetic Therapy: a Systematic Review and Network Meta‐analysis [Internet]. In: Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/all/Disease‐modifying_antirheumatic_drugs__DMARDs__for_rheumatoid_arthritis_after_failure_of_biologic_or_targeted_synthetic_therapy:_a_systematic_review_and_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Disease‐modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta‐analysis
ID - 438879
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/all/Disease‐modifying_antirheumatic_drugs__DMARDs__for_rheumatoid_arthritis_after_failure_of_biologic_or_targeted_synthetic_therapy:_a_systematic_review_and_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
